The accumulation of senescent cells in aging tissues is a significant contributor to age-related degenerative conditions. Researchers are developing senolytic drugs to selectively destroy these cells, with promising results in animal studies. Flavonoid compounds like quercetin and fisetin have shown some senolytic properties, and a recent study has found that 4,4′-dimethoxychalcone (DMC) may also be senolytic. DMC, in combination with other compounds, effectively eliminates senescent cells and reduces the senescence-associated secretory phenotype. This research suggests that flavonoids hold promise as potential senolytic treatments, though further studies are needed to determine their efficacy in humans.